National Foundation for Infectious Diseases

Please visit www.nfid.org to access additional information
and resources related to this Media Forum.

A Media Forum

ARCHIVED VIDEO WEBCAST
Original live broadcast:
Thursday, May 18, 2006 at 10:00am EASTERN TIME

EVOLVING ISSUES IN THE PREVENTION AND
TREATMENT OF INFLUENZA
A MEDIA FORUM

National Press Club, Peter Zenger Room, Washington, D.C.

Presented by
National Foundation for Infectious Diseases (NFID)

In Collaboration with
U.S. Department of Health and Human Services (HHS)
U.S. Centers for Disease Control and Prevention (CDC)
U.S. Food and Drug Administration (FDA)
National Vaccine Program Office (NVPO)
National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)
American Medical Association (AMA)
American Academy of Pediatrics (AAP)

VIEW ARCHIVED WEBCAST:

Windows Media Player format

Real Player format

IMPORTANT Viewing Notes:

Accessing the webcast requires RealPlayer® or Windows Media Player® software.


CLICK HERE to download and install the free RealPlayer® software.

CLICK HERE to download and install the Windows Media Player
® software.



If you need technical support to view the webcast, please direct your questions to support@ConnectLive.com


Please note that after downloading the free software you must install it on your computer in order to view the webcast.

Agenda

10:00 a.m. Program Introduction and Overview
Moderator: William Schaffner, MD, NFID Board Member and Vanderbilt University School of Medicine
10:10 a.m. Impact of Improved Seasonal Influenza Immunization Rates on Public Health Goals
Cristina V. Beato, MD, FAAFP, Principal Deputy Assistant Secretary of Health, U.S. Department of Health and Human Services
10:15 a.m. CDC's Role in Influenza Surveillance, Immunization Recommendations and Appropriate Antiviral Use
Ray Strikas, MD, National Vaccine Program Office, U.S. Department of Health and Human Services
10:25 a.m. CDC's Role in Influenza Surveillance, Immunization Recommendations and Appropriate Antiviral Use
Nicole M. Smith, MD, Influenza Division, Centers for Disease Control and Prevention
10:40 a.m. Influenza Vaccine Production
Jesse L. Goodman, MD, MPH, Director, Center for Biologics Evaluation and Research, Food and Drug Administration
10:55 a.m. Influenza Vaccine Supply and Distribution
Christine M. Layton, PhD, MPH, RTI International
11:10 a.m. Evolving Vaccine Development Technologies
George T. Curlin, MD, Office of the Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
11:20 a.m. National Immunization Programs
Ardis D. Hoven, MD, Board of Trustees, American Medical Association
11:30a.m. Pediatric Perspectives on Influenza Prevention
Henry H. Bernstein, DO, Committee on Infectious Diseases, American Academy of Pediatrics
11:40a.m. Annual Provider and Consumer Education
Glen Nowak, PhD, Director, Media Relations, Centers for Disease Control and Prevention
11:50a.m. Media Questions and Answers Session
Buffet Lunch Available
12:30p.m. Adjourn

 

This Media Forum is supported by an unrestricted educational grant to the National Foundation for Infectious Diseases from sanofi pasteur.


WEBCAST ARCHIVES:
ACCESS THE 2005 NFID PRESS CONFERENCE HERE
ACCESS THE 2004 NFID PRESS CONFERENCE HERE
ACCESS THE 2003 NFID PRESS CONFERENCE HERE